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Abstract 
The inhibiting or inactivating effects of position-specific promoter methylation in different viral or human cellular promoters Ad2 E2AL, SV40, 
LTR-MMTV, HSV-tk, TNFa) have been compared by in vitro 5’-CCGG-3’ methylation by M-&a11 or the M-&I DNA-methyltransferase, 
respectively. In most promoters, 5’-CG-3’ methylation reduces activity to a few percent of that of mock-methylated controls. The number of 5’-CG-3’ 
dinucleotides in a promoter does not strictly correlate with the extent of methylation inhibition. The LTR-MMTV promoter, which lacks 5’-CG-3’ 
dinucleotides, is not affected by methylation. The late E2A promoter of Ad2 DNA cannot be inactivated by 5’-CCGG-3’ methylation when the 
construct carries the strong cytomegalovirus enhancer devoid of this sequence. In contrast, 5’-CG-3’ methylation shuts this promoter off even in the 
presence of this enhancer. 
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1. Introduction 
Through studies on many different eukaryotic pro- 
moters the concept that sequence-specific DNA methyla- 
tion can lead to the inactivation of promoters [l] has 
gained acceptance (see references in [2]). The methyla- 
tion-sensitive site(s) in a given promoter cannot be pre- 
dicted but must be experimentally determined. It is likely 
that promoter methylation interferes with transcription 
factor binding [3-61 or promotes the binding of methyl 
group-dependent factors to promoter motifs [7]. This 
interpretation could explain why the methylation of dif- 
ferent promoter motifs is associated with gene inactiva- 
tion. 
We have shown previously that sequence-specific pro- 
moter methylation inactivates the RNA polymerase II- 
transcribed late E2A promoter of adenovirus type 2 
(Ad2) DNA [8-111, the ElA promoter of Ad12 DNA 
[12], the major late promoter of Ad2 DNA [13] or even 
the p10 gene promoter of the insect virus, Autograph 
californica, nuclear polyhedrosis virus DNA in insect 
cells [14]. The RNA polymerase III-transcribed elements 
for VA (virus associated) RNA of Ad2 DNA [15] and 
Alu elements from the human genome [ 161 are also tran- 
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scriptionally inhibited by the sequence-specific methyla- 
tion of control sequences in these elements. 
Here, we report on the results of a comparative study 
testing the effects of 5’-CG-3’ methylation on the activi- 
ties of the late E2A promoter of Ad2 DNA, the early 
SV40 promoter, the LTR (long terminal repeat)-located 
promoter of mouse mammary tumor virus (MMTV), the 
thymidine kinase promoter from herpes simplex virus 
(HSV), and of the promoter of the human tumor necrosis 
factor (TNF) CI gene. With the exception of the early 
SV40 promoter, which is strongly inhibited, 5’-CG-3’ 
methylation practically inactivates all the other promot- 
ers tested. 
2. Materials and methods 
2.1. Cell lines used in transfection experiments 
Human HeLa cells (ATCC CCL 2), a cervical carcinoma cell line, the 
human PA-l cell line derived from an ovarian teratocarcinoma (ATCC 
CRL 1572) [17], and the AdS-transformed human cell line, 293 [18], 
were propagated in Dulbecco’s medium enriched with 10% fetal calf 
serum. 
2.2. Plasmids employed in this study 
Table 1 presents an overview of all plasmid constructs used, the 
promoters and the reporter genes, and lists the derivation of these 
constructs, 
2.3. Newly made plasmid constructs 
2.3.1. pAd2-E2AL-LUX. The 490 bp Hind111 fragment carrying 
the late E2A promoter of Ad2 DNA was re-cloned into the Hind111 site 
of the plasmid, pGB-Basic (Promega). 
2.3.2. pTNFaEN-CAT(-LUX). The 632 bp SmaI-EcoNI (-615 
to + 17) fragment from the human TNFa gene promoter [26] was 
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treated with Klenow polymerase [27] and cloned into the SmaI site of 
PBS’ (Stratagene, LaJolla, CA, USA). From this construct, the TNFa 
promoter was re-cloned into the pSVO-CAT plasmid as a HindIII-N&I 
fragment or into the pGL-Basic plasmid as a HindIIII@zI fragment. 
2.3.3. pTNFa HP-CAT(-LUX). The 795 bp HpaII fragment 
(-592 to + 203) of the human TNFa gene promoter was cloned first 
into the AccI site of the pBSC vector and then re-cloned into the pSVO- 
CAT plasmid as a Hind15N&I fragment or into the pGL-Basic plas- 
mid as a HindIII-KpnI fragment. 
Plasmid constructs were prepared using standard cloning techniques. 
Plasmid DNAs were purified by using Qiagen (Diagen, Hilden, Ger- 
many) Midi- and Maxiprep systems. 
[ 12,191 and expressed as percent conversion of chloramphenicol (CAM) 
to acetylated CAM forms during a 1 h incubation. Activity of B-galac- 
tosidase was determined according to Hall et al. [21] and expressed in 
arbitrary units. LUX activity was determined using the Promega assay 
system and a Lumat LB9501 luminometer (Berthold, Bad Wildbad, 
Germany). LUX activity was expressed in relative light units. Reporter 
gene activities were normalized relative to the amounts of cellular pro- 
tein in culture lysates. Protein concentration was determined according 
to [30]. The data presented in the tables were typical values derived from 
at least 3, but in most cases from 10-12 independent transfection exper- 
iments. 
2.4. The in vitro methylation of DNA 
Plasmid DNAs were methylated in vitro by the bacteria1 M-HpaII 
(MBI-Fermentas, Vilnius, Lithuania) or by the M-&s1 (CpG) [28] 
DNA-methyltransferase (New England Biolabs, Beverly, MA, USA, or 
Amersham-USB, Cleveland, OH, USA). NEB buffer No. 2 was made 
160,uM S-adenosylmethionine (SAM) and used in all methylation reac- 
tions which proceeded for 24 h at 37°C using 2 U of enzyme per pg 
of DNA in a volume of lo@. In mock-methylation reactions, SAM was 
omitted. At the end of the methylation or mock-methylation reaction, 
DNA was re-extracted by phenol-chloroform and ether, ethanol pre- 
cipitated, washed with 70% ethanol and resuspended at a final DNA 
concentration of 1 fig in 10~1 of 0.01 M Tris-HCl, pH 7.5,l mM EDTA 
(TE). Complete methylation was assessed by restricting DNA with 
HpaII or by determining the nucleotide sequence. In addition, changes 
in plasmid topoisomer distributions were tested by electrophoresis of 
uncut DNA in 0.8% agarose gels. All enzyme preparations used pro- 
duced remarkable relaxation of the supercoiled form of plasmid DNA 
both in mock- and methylation reactions. Plasmid preparations with an 
excess of relaxed plasmid topoisomers were not used in transfection 
experiments. 
3. Results and discussion 
3.1. Aim of project 
2.5. Transfection and reporter gene activity assays 
Human cell lines were transfected 24 h after re-plating with pro- 
moter-reporter gene constructs by the calcium phosphate precipitation 
technique [29]. Amounts of 2-5 pg of plasmid DNA were used per 5 
cm diameter dish of HeLa or 293 cells, and 0.551 .O pg for PA-l cells. 
The published protocol was applied with the following modifications: 
the HEPES buffer solution was pH 6.96; the glycerol shock step was 
omitted; medium was first changed 24 h after the addition of the DNA- 
Ca2’ precipitates; the cells were harvested 48 h after transfection. 
We have previously shown that the late E2A promoter 
of Ad2 DNA can be inhibited or inactivated by in vitro 
methylation at the S-CCGG-3’ sequences [9,11]. We 
have now compared this promoter activity upon methyl- 
ation at the three 5’-CCGG-3’ sequences at + 6, + 24, 
and -215 relative to the cap site at + 1 with its activity 
when all S-CG-3’ sequences were methylated by differ- 
ent DNA-methyltransferases and upon transfection of 
these methylated constructs into different human cell 
lines. We have also demonstrated that the 13s ElA func- 
tion of Ad2 or of Ad5 DNA can overcome, at least 
partly, the inhibitory effect of methylation in this pro- 
moter [11,23]. Similarly, presence of the strong early 
enhancer from human cytomegalovirus (HCMV) coun- 
teracts the inactivating function of 5’-CCGG-3’ methyla- 
tion in the late E2A promoter [24]. 
CAT activity was determined according to standard procedures 
It has been the second aim of this study to compare 
the effects of 5’-CCGG-3’ with those of 5’-CG-3’ methyl- 
ation on a series of viral and mammalian cellular pro- 
moter constructs to underline the fact that results derived 
Table 1 
Plasmid constructs used in transcription experimentsa 
Plasmid Promoter Reporter gene Reference 
pSV2-CAT SV40 early CAT 1191 
pSVO-CAT none CAT 1191 
pBLCAT2 HSV tk CAT PO1 
pCHll0 SV40 early /I-Gal P.11 
pMMTV MMTV-LTR /?-Gal i221 
pAd2E2ALCAT EZAL CAT ~231 
pAd2E2AL-HCMV-CAT EZAL+HCMV CAT ~241 
pAd2E2AL-HCMV (Barn-CAT) E2AL-HCMV CAT 1241 
pGL-Control SV40 early LUX Promega, Madison, WI, USA 
pGB-Basic none LUX Promega 
pAd2E2AL-LUX E2AL LUX This work 
pTNFa-EN-CAT P-TNFa CAT This work 
pTNFa-HP-CAT P-TNFa CAT This work 
pTNFa-EN-LUX P-TNFa LUX This work 
pTNFa-HP-LUX P-TNFa LUX This work 
pE2AL-A46-CAT E2A-A46 CAT 1251 
Promoters: SV40 early, Simian virus 40 early region of transcription; HSV tk, Herpes simplex virus thymidylate kinase; E2AL, adenovirus type 2 
late E2A gene promoter; pTNFa, human tumor necrosis factor a gene promoter; MMTV-LTR, mouse mammary tumor virus long terminal repeat; 
HCMV, human cytomegalovirus immediate early enhancer; Reporter genes: CAT, chloramphenicol acetyltransferase; LUX, firefly luciferase; /I-Gal, 
bacterial /I-galactosidase. 
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Table 2 
5’-CpG-3’ methylated E2A late gene promoter is inactivated 
Plasmid Methylation by Cell line used for transfection 
construct DNA-methyltrans- (% activity) 
ferase from 
HeLa PA-l 293 
pAd2-E2AL- M-HpaII 20 25 100 
CAT M-&I < 1 2 1 
pAd2-E2AL- M-HpaII 100 100 NDb 
HCMV-CAT M-SssI <l 3 ND 
PAd2-E2AL- M-HpaII 
HCMV(Bam)- M-&I 
CAT 
100 100 ND 
2 3 ND 
“Activities of promoter constructs were expressed as percent activity of 
mock-methylated promoter, which was arbitrarily set at 100%. 
bND = not determined. 
from viral promoter systems are valid for human cell 
promoters as well. 
3.2. The methylation of S-CG-3’ sequences inactivates 
the late E2A promoter of Ad2 DNA 
The data in Table 2 document that 5’-CG-3’ methyla- 
tion of the late E2A promoter of Ad2 DNA by the M- 
SssI DNA-methyltransferase from Spiroplasma spp. in- 
activates this promoter, even in the presence of the 
HCMV enhancer. As described earlier [24] and recon- 
firmed by some of the results in Table 2, 5’-CCGG-3’ 
methylation by the M-HpaII DNA-methyltransferase 
does not even slightly affect the activity of late E2A 
promoter-CAT gene constructs which contain the strong 
HCMV enhancer. These data can probably be explained 
by the fact that the HCMV enhancer [31] does not carry 
a single HpaII site, but seventeen 5’-CG-3’ dinucleotides 
which render it susceptible to M-&s1 methylation. The 
silencing of the late E2A promoter of Ad2 DNA by 
complete 5’-CG-3’ methylation cannot be overcome ei- 
ther by the ElA adenovirus functions which are constitu- 
tively expressed in the human cell line, 293 (Table 2). In 
contrast, the inhibitory effect of 5’-CCGG-3’ methyla- 
tion of the late E2A promoter by the M-HpaII DNA- 
methyltransferase is counteracted by the ElA functions 
present in 293 cells. The transactivating effect of the ElA 
13s gene product on the late E2A promoter [ 1 l] is obvi- 
ously compromised when all 5’-CG-3’ dinucleotides are 
methylated. 
It should be mentioned that the absolute strength of 
the three promoter constructs presented in Table 2 differ 
and is highest in the human PA-l teratocarcinoma cell 
line. The presence of the HCMV enhancer in two of the 
unmethylated constructs raises their absolute activities 
by a factor of about ten (data not shown). 
3.3. Different promoters differ in activity upon 
transfection into human HeLa cells 
Prior to determining the effect of 5’-CG-3’ methylation 
on different viral and human cell promoters, the relative 
activities of these promoters were assessed in combina- 
tion with three different indicator genes upon transfec- 
tion into human HeLa cells. The relative values are jux- 
taposed in Table 3 and demonstrate the following: 
(i) With the exception of the early SV40 and possibly the 
HSV-tk promoters, all other promoter-reporter gene 
constructs have about comparable relative activities in- 
dependent of the indicator genes used (CAT, /I-Gal, or 
LUX). The early SV40 and the HSV tk promoters have 
higher activities with the CAT reporter gene. (ii) Two 
slightly differently designed human TNFa gene pro- 
moter constructs exhibit appreciable activities, similar in 
conjunction both with the CAT and LUX gene reporters. 
3.4. The human TNFc gene promoter is expressed in 
human epithelial cell lines and is completely 
inactivated by 5’-CG-3’ methylation 
In both human HeLa (Table 3) and PA-l cells, the 
TNFa gene promoter activates the CAT and LUX re- 
porter genes. This activity is unaffected by TNFcl induc- 
ers, such as phorbol ester or bacterial lipopolysac- 
charides (data not shown). As shown by the results of 
5’-CG-3’ methylation experiments in Table 4, the human 
TNFcl promoter is almost completely inactivated by this 
modification. 
3.5. Promoter inactivation by S-CG-3’ methylation: a 
comparative study 
The presentation of data in Table 4 correlates the 
Table 3 
Relative activities in HeLa cells of different promoters with the same 
reporter gene 
Promote? Number of Relative strength of promoters in HeLa 
5’-CC-3’ cells with different reporter genes 
dinucleo- 
tide? 
CAT /?-Gal LUX 
E2AL 11 1 NDd 1 
E2AL-A46” 11 0.5 ND ND 
TNFa-EN 4 2 ND 3 
TNFa-HP 4 0.5 ND 5 
SV40 early 7 300 3 10 
MMTV 0 ND 1 ND 
HSV tk 16 10 ND ND 
“Relative strength of promoters was compared in constructs carrying 
different promoters but the same reporter gene. 
bNumber of 5’-CG-3’ inucleotides in 120 nucleotides upstream from the 
cap site. 
“In this promoter construct, the nucleotide + 7 to + 52 sequence relative 
to the + 1 cap site in the late E2A promoter encompassing the + 6 and 
+ 24 5’-CCGG-3’ site was deleted [25]. 
dND = not determined. 
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